Last reviewed · How we verify
NCT04758026
H&N Cancer; Survivorship and Late Effects
trial in Head and Neck Neoplasms in 265 participants. Completed in 10 October 2020.
10 October 2020
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 265 |
| Start date | 10 October 2018 |
| Primary completion | 10 October 2020 |
| Estimated completion | 10 October 2020 |
| Sites | 1 location across Norway |
Conditions studied
- Head and Neck Neoplasms — all drugs for Head and Neck Neoplasms →
- Survivorship — all drugs for Survivorship →
Sponsor
Oslo University Hospital
Who can join
18 and older, any sex, with Head and Neck Neoplasms or Survivorship. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A cross-sectional study on late effects after modern treatment in long-term survivors of head and neck cancer (HNC). Participants fill in questionnaires and participate at a one day visit at the hospital including blood sample with biomarkers, clinical examination, audiometry, oral radiological examination and oral examination. Data on patients' medical history collected from medical records including radiology images and digital radiotherapy plans.This will allow adjustments of treatment planning and improved treatment decisions for patients at risk, and improve information and follow up for future patients.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects.
Ivanova A, Rodríguez-Cano R, Kvalem IL, Harcourt D, et al · · 2023 · cited 7× · PMID 36509859 · DOI 10.1007/s11764-022-01311-y -
Multidomain predictors of long-term work disability in late survivorship after head and neck cancer.
Ivanova A, Amdal CD, Kvalem IL, Reme SE. · · 2026 · PMID 41772198 · DOI 10.1007/s00520-026-10524-1
Verify or expand the search:
- PubMed search for NCT04758026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Head and Neck Neoplasms
Currently open trials in the same condition.
- NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
- NCT06912087 — Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC · Phase 1 · recruiting
- NCT06998069 — Head and Neck Cancer Study Project in the Geriatric Population · Phase 3 · recruiting
- NCT07158164 — DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment · Phase 4 · recruiting
- NCT06303180 — NIDCD Otolaryngology Clinical Protocol Biospecimen Bank · recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04758026 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04758026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing